Back to Agenda
Session 12: Risk Assessment in Clinical Trials
Session Chair(s)
William Gregory, PhD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
This session will address premarketing risk assessment, mathematics of drug safety, and a brief introduction to benefit-risk (to be discussed further in Session 20).
Have an account?